Company Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Equities
300760
CNE100003G67
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 194.81 CNY | -1.12% |
|
-1.96% | -23.60% |
Business description: Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Number of employees: 21,667
Sales by Activity: Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
Surgical & Medical Equipment | 21.03B | 25.27B | 30.37B | 34.93B | 36.73B |
Geographical breakdown of sales: Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
China | 11.11B | 15.26B | 18.67B | 21.38B | 20.29B |
Others | 2.86B | 2.13B | 2.86B | 3.7B | 4.45B |
Asian-Pacific | 1.55B | 2.17B | 2.28B | 2.64B | 3.66B |
Europe | 2.31B | 2.27B | 2B | 2.19B | 2.89B |
Latin America | 1.53B | 1.57B | 2.1B | 2.42B | 2.8B |
North America | 1.68B | 1.87B | 2.46B | 2.6B | 2.64B |
Executive Committee: Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
| Manager | Title | Age | Since |
|---|---|---|---|
Hao Wu
CEO | Chief Executive Officer | 53 | 2020-11-16 |
Yun Zhao
DFI | Director of Finance/CFO | 42 | 2019-11-14 |
Yan Mei Guo
PRN | Corporate Officer/Principal | 62 | 2021-04-26 |
Wen Mei Li
SEC | Corporate Secretary | 45 | 2017-01-04 |
Composition of the Board of Directors: Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
| Director | Title | Age | Since |
|---|---|---|---|
Hang Xu
CHM | Chairman | 63 | 1999-01-24 |
Xi Ting Li
CHM | Chairman | 74 | 2001-12-17 |
Ming He Cheng
BRD | Director/Board Member | 64 | 2017-01-04 |
Zhi Tang
CHM | Chairman | 47 | 2016-07-26 |
Min Jiang
BRD | Director/Board Member | 63 | 2015-12-31 |
Hao Wu
BRD | Director/Board Member | 53 | 2017-01-04 |
Yan Mei Guo
BRD | Director/Board Member | 62 | 2017-01-04 |
Jing Xu
BRD | Director/Board Member | 57 | 2023-05-17 |
Sheng Ping Gao
BRD | Director/Board Member | 59 | 2023-05-17 |
Shan Rong Hu
BRD | Director/Board Member | 73 | 2023-05-17 |
Company details: Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
High-Tech Industrial Park
518057, Shenzhen
+
http://www.mindray.com
Other Advanced Medical Equipment & Technology
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.12% | -1.96% | -23.21% | -37.31% | 33.46B | |
| -1.00% | +1.26% | +7.52% | +6.29% | 214B | |
| -0.88% | -0.64% | +2.32% | +109.53% | 197B | |
| -1.68% | +0.66% | -4.05% | -14.25% | 159B | |
| +0.82% | +0.45% | +2.75% | +102.90% | 138B | |
| -0.79% | +2.61% | -17.24% | -6.82% | 58.08B | |
| +2.33% | +2.45% | +15.44% | +16.86% | 49.51B | |
| -1.00% | -1.03% | +1.10% | -6.77% | 39.4B | |
| -2.61% | -0.94% | +2.44% | +44.96% | 37.47B | |
| -2.26% | +0.33% | +2.62% | +17.89% | 36.05B | |
| Average | -0.81% | +0.24% | -1.03% | +23.33% | 96.13B | |
| Weighted average by Cap. | -0.75% | +0.42% | +1.06% | +37.50% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 300760 Stock
- Company Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition